LD-2 disclosure · 2nd Quarter - Report
STEALTH BIOTHERAPEUTICS INC.
via STEALTH BIOTHERAPEUTICS INC.
Client
- Name
- STEALTH BIOTHERAPEUTICS INC.
- Description
- Developing therapies to treat mitochondrial dysfunction.
- Location
- Massachusetts · United States of America
Registrant
- Firm
- STEALTH BIOTHERAPEUTICS INC.
- Location
- Needham, Massachusetts, United States of America
Lobbying activities
1 issueHealth Issues
H.R. 7384/S. 4583, the Creating Hope Reauthorization Act of 2024 (118th Congress) H.R. 1509/S. 752 the Accelerating Kids Access to Care Act H.R. 1262/S. 932 - Give Kids a Chance Act of 2025 General discussions about ultra-rare disease drug development General discussions about regulatory reform, including scientific-focused drug development meetings H.R. 1092/S. 526, the BENEFIT Act (118th Congress) General discussions about mitochondrial diseases H.R. 1532/S. 822, the Scientific EXPERT Act of 2025 General discussions about ultra-rare diseases FDA Rare Disease Innovation Hub ORPHAN Cures Act (H.R. 946 / S. 1862) [part of One, Big, Beautiful Bill Act (H.R 1)] Fiscal Year 2026 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R. 4121 / S. 2256)
Lobbyistsms KATHERINE LANDES
TargetedSENATE · HOUSE OF REPRESENTATIVES